# Tradjenta

NDC: 55154-0410
Generic name: linagliptin
Labeler / Manufacturer: Cardinal Health 107, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20110509

FDA application: NDA201280

## Active ingredients

- LINAGLIPTIN: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55154-0410"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55154-0410
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfe327e8-f6ab-41e5-bdef-d520118cd83a